By Dr. Raj Dhadwal
Your eyes ache by the end of a workday that was mostly a screen. You blink and the ache does not really go away, and somewhere in the back of your mind there is a quieter worry underneath the daily one: what is all this screen time actually doing to my eyes over the years, not just today. That second worry is the one this article is for.
This is education about eye physiology, screen use and dietary carotenoids, not medical advice, and nothing here describes treating, curing or preventing any eye condition, including age-related macular degeneration. If you have persistent symptoms, changes in your vision, or a family history of eye disease, see an eye-care clinician for assessment, because that is the only way to actually know what is happening in your eyes.
What is the macula, and why does it matter for a screen habit?
Sit in the centre of your retina, the light-sensing layer at the back of your eye, and you find a small, densely packed region called the macula. It is only a few millimetres across, but it does an outsized amount of work: it is responsible for your sharp, central vision, the kind you use to read a sentence, recognise a face, or focus on the exact pixel you are looking at on a screen. The rest of your retina handles peripheral and low-light vision; the macula is what lets you see detail.
Because the macula is doing constant, high-resolution work, and because it sits directly in the path of light entering the eye, it is also a site of ongoing metabolic and light-related stress. The retina has among the highest oxygen consumption of any tissue in the body, and that combination of high oxygen use and constant light exposure creates oxidative load, byproducts of normal cellular activity that, over time and left unmanaged, are associated with age-related changes in the macula. This is normal physiology, not a disease process on its own; every eye experiences it.
What is macular pigment, and where does it come from?
The macula is yellow. That colour is not incidental, it comes from two carotenoids, lutein and zeaxanthin, that concentrate there at far higher density than anywhere else in the body, plus a related carotenoid, meso-zeaxanthin, that the eye itself converts from the other two. Together they are called macular pigment, and the eye cannot make lutein or zeaxanthin on its own. Every molecule of it arrives through diet and gets selectively transported and concentrated into that small central region.
Researchers describe macular pigment as doing two jobs. The first is filtering: lutein and zeaxanthin absorb strongly in the blue part of the visible light spectrum, the higher-energy, shorter-wavelength light, before it reaches the more light-sensitive photoreceptor cells underneath. The second is antioxidant activity, neutralising some of the reactive byproducts generated by that light exposure and by the retina's own high oxygen turnover. Both mechanisms are physiology, describing what the pigment does at a cellular level, not a claim about what any product does for a person's eyesight.
Where do screens fit into this?
Digital devices emit light across the visible spectrum, including a blue-light component, and screen use is now the dominant visual task for a large share of the population. A 2023 systematic review from the Tear Film and Ocular Surface Society examined the digital environment's effect on the eye and reported digital eye strain prevalence estimates as high as 97 percent in some populations, driven mainly by reduced blink rate and completeness during screen tasks rather than blue light exposure itself; the same review found current evidence does not support blue-light-blocking interventions as an effective management strategy, and noted nutritional approaches, including berry extracts and omega-3 fatty acids, as a promising but still early area (Wolffsohn and colleagues, The Ocular Surface, 2023, DOI). That review is about ocular surface symptoms, the gritty, tired feeling on the front of the eye, which is a different structure from the macula at the back of the eye that this article is mainly about. It is included here because it is the most direct published evidence on what screen use actually does to the eye, and because it is honest about how much still is not established.
What research has looked at more directly for the macula is whether increasing dietary lutein and zeaxanthin raises macular pigment optical density, a measurable marker of how much of the pigment is present. A 2026 randomized, double-blind, placebo-controlled trial in teenagers with high screen use and diets low in fruit and vegetables gave 10 mg lutein and 2 mg zeaxanthin daily for six months and reported a measurable increase in macular pigment optical density in both eyes compared to placebo, along with improvements on some tests of attention and processing speed, though not on every cognitive measure tested (Lopresti and Smith, Nutrition Research, 2026, DOI). That is what the trial measured: a dietary-supplement dose raised a pigment-density marker in a specific study population over six months. It is not a study of sea buckthorn, and a marker increasing is not the same thing as a vision outcome changing.
What did the large AMD trial actually find?
The most cited study connecting these carotenoids to eye disease is the Age-Related Eye Disease Study 2 (AREDS2), a large, multicenter, randomized, double-masked, placebo-controlled trial of 4,203 participants already at risk for progressing to advanced age-related macular degeneration. It tested adding 10 mg lutein and 2 mg zeaxanthin, or omega-3 fatty acids, or both, to an existing antioxidant-and-zinc formula. Reported plainly, because the honest reading matters more than the flattering one: over a median five years of follow-up, adding lutein and zeaxanthin did not produce a statistically significant reduction in progression to advanced AMD in the trial's primary analysis (hazard ratio 0.90, P = .12) (Age-Related Eye Disease Study 2 Research Group, JAMA, 2013, DOI). The trial did find a secondary safety signal worth naming: more lung cancers were observed in participants taking beta-carotene versus those who were not, mostly in former smokers, which is one reason lutein and zeaxanthin are now often used as a beta-carotene substitute in eye-health formulations rather than because they proved themselves therapeutically superior in that trial.
That result belongs in this article precisely because it complicates a tidy story. AREDS2 is what a well-designed, large clinical trial found about carotenoid supplementation and an eye disease outcome, and the finding was a null result on the primary endpoint, not a confirmed benefit. Citing it as proof that lutein and zeaxanthin protect vision would misstate what the trial actually showed. What the broader research area does support, consistently, is that these two carotenoids are the ones the eye selectively concentrates into the macula and that dietary intake is their only source; what it has not established is that raising intake changes disease outcomes for a general, healthy population eating normally, including anyone drinking sea buckthorn puree.
Where does sea buckthorn sit?
Human Renaissance is the only sea buckthorn puree in the world sold in a single-serve pouch. 190+ naturally occurring compounds, omega 3, 6, 7 and 9, 201 mg of vitamin C per pouch, 0 g sugar, 5,640 hand-picked berries per box.
Zeaxanthin is part of that composition. In the one fully published wild-population breakdown, zeaxanthin was in fact the single largest carotenoid measured in the berry, ahead of beta-carotene, the details are in zeaxanthin in sea buckthorn. This is composition, a fact about what is naturally present in the fruit, not a claim that drinking the puree protects the macula, supports vision, or affects any eye condition. The studies discussed above used isolated supplement doses of lutein and zeaxanthin in specific study populations, not whole-berry sea buckthorn puree in a general population, and no research has measured what this product's zeaxanthin content does to macular pigment or to any eye outcome. Composition and effect are two different questions, and only the first one has an honest answer here.
The dry-eye side of screen use, a different question from the macula, involving the tear film on the front of the eye rather than the retina at the back, is covered separately in why are my eyes so dry and tired by the end of the day. The full nutritional profile of the puree, including where its other compounds come from, is in sea buckthorn nutrition facts.
What should you actually do about screen-related eye concerns?
The measures with the most direct evidence behind them are unglamorous. Take regular breaks from continuous screen use, a commonly recommended pattern is to look at something roughly 20 feet away for 20 seconds every 20 minutes. Blink fully and deliberately during screen tasks, since reduced blink rate and completeness, not blue light, is what the 2023 ocular-surface review identified as the main driver of digital eye strain. Get your eyes examined regularly, especially if you have a family history of macular degeneration or other eye disease, because a clinician can measure things, like macular pigment density or early retinal changes, that no amount of reading about diet can substitute for. If you are considering a supplement specifically for eye health, discuss the dose and the evidence with an eye-care professional rather than deciding from an article, including this one.
The short version
The macula is the small, central part of your retina responsible for sharp vision, and it concentrates two dietary carotenoids, lutein and zeaxanthin, at higher density than anywhere else in the body, where they filter blue light and support antioxidant activity as part of normal eye physiology. Screens are a major visual task for most people today, and while the strongest published evidence on screens ties them to digital eye strain and reduced blink rate rather than direct macular harm, researchers have studied whether raising dietary lutein and zeaxanthin increases macular pigment density, with some trials, including a 2026 study in screen-heavy teenagers, reporting a measurable increase. The largest and most rigorous trial on an actual disease outcome, AREDS2, found no statistically significant benefit from added lutein and zeaxanthin on the primary endpoint of progression to advanced macular degeneration. Zeaxanthin is naturally present in sea buckthorn, in fact the largest single carotenoid measured in the one fully published wild-population dataset, and that is a fact about composition, not a claim that the puree affects your eyes. You do not have to guess whether a bottle's marketing claim about eye health is backed by the trial it is citing. You can turn the pouch over, read the single ingredient for yourself, and decide. This is education about nutrition and physiology, not medical advice, and nothing here treats, cures or prevents any condition.
